{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:17:14Z","timestamp":1794007034963,"version":"4.8.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T00:00:00Z","timestamp":1561420800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F&amp;#x00F6;rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32003B_138434"],"award-info":[{"award-number":["32003B_138434"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F&amp;#x00F6;rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["169805"],"award-info":[{"award-number":["169805"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"name":"CTU-Forschungs-Grants der Insel Gruppe"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Vascularized composite allotransplantation (VCA), such as hand and face transplantation, is emerging as a potential solution in patients that suffered severe injuries. However, adverse effects of chronic high-dose immunosuppression regimens strongly limit the access to these procedures. In this study, we developed an\n                    <jats:italic>in situ<\/jats:italic>\n                    forming implant (ISFI) loaded with rapamycin to promote VCA acceptance. We hypothesized that the sustained delivery of low-dose rapamycin in proximity to the graft may promote graft survival and induce an immunoregulatory microenvironment, boosting the expansion of T regulatory cells (T\n                    <jats:sub>reg<\/jats:sub>\n                    ).\n                    <jats:italic>In vitro<\/jats:italic>\n                    and\n                    <jats:italic>in vivo<\/jats:italic>\n                    analysis of rapamycin-loaded ISFI (Rapa-ISFI) showed sustained drug release with subtherapeutic systemic levels and persistent tissue levels. A single injection of Rapa-ISFI in the groin on the same side as a transplanted limb significantly prolonged VCA survival. Moreover, treatment with Rapa-ISFI increased the levels of multilineage mixed chimerism and the frequency of T\n                    <jats:sub>reg<\/jats:sub>\n                    both in the circulation and VCA-skin. Our study shows that Rapa-ISFI therapy represents a promising approach for minimizing immunosuppression, decreasing toxicity and increasing patient compliance. Importantly, the use of such a delivery system may favor the reprogramming of allogeneic responses towards a regulatory function in VCA and, potentially, in other transplants and inflammatory conditions.\n                  <\/jats:p>","DOI":"10.1038\/s41598-019-45759-y","type":"journal-article","created":{"date-parts":[[2019,6,25]],"date-time":"2019-06-25T17:52:50Z","timestamp":1561485170000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival"],"prefix":"10.1038","volume":"9","author":[{"given":"Damian","family":"Sutter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dzhuliya V.","family":"Dzhonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8820-706X","authenticated-orcid":false,"given":"Jean-Christophe","family":"Prost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric","family":"Bovet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yara","family":"Banz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Rahnfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4179-8891","authenticated-orcid":false,"given":"Robert","family":"Rieben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"V\u00f6gelin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan A.","family":"Plock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3281-1548","authenticated-orcid":false,"given":"Adriano","family":"Taddeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas T.","family":"Schnider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,25]]},"reference":[{"issue":"3","key":"45759_CR1","doi-asserted-by":"publisher","first-page":"a015651","DOI":"10.1101\/cshperspect.a015651","volume":"4","author":"B. Pomahac","year":"2014","unstructured":"Bohdan Pomahac, R. M. G. Facial and Hand Allotransplantation. Cold Spring Harbor perspectives in medicine, https:\/\/doi.org\/10.1101\/cshperspect.a015651 (2014).","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"key":"45759_CR2","doi-asserted-by":"publisher","first-page":"351e","DOI":"10.1097\/PRS.0000000000000892","volume":"135","author":"JT Shores","year":"2015","unstructured":"Shores, J. T., Brandacher, G. & Lee, W. P. A. Hand and Upper Extremity Transplantation: An Update of Outcomes in the Worldwide Experience. Plastic and reconstructive surgery 135, 351e\u2013360e (2015).","journal-title":"Plastic and reconstructive surgery"},{"key":"45759_CR3","first-page":"e495212","volume":"2013","author":"JT Schnider","year":"2013","unstructured":"Schnider, J. T. et al. Site-Specific Immunosuppression in Vascularized Composite Allotransplantation: Prospects and Potential. Journal of Immunology Research 2013, e495212 (2013).","journal-title":"Journal of Immunology Research"},{"key":"45759_CR4","doi-asserted-by":"publisher","first-page":"17S","DOI":"10.1097\/PRS.0b013e318191bcbd","volume":"123","author":"MG Solari","year":"2009","unstructured":"Solari, M. G. et al. Daily topical tacrolimus therapy prevents skin rejection in a rodent hind limb allograft model. Plastic and reconstructive surgery 123, 17S\u201325S (2009).","journal-title":"Plastic and reconstructive surgery"},{"key":"45759_CR5","doi-asserted-by":"publisher","first-page":"1197","DOI":"10.1097\/TP.0b013e31828bca61","volume":"95","author":"BB Gharb","year":"2013","unstructured":"Gharb, B. B. et al. Effectiveness of topical immunosuppressants in prevention and treatment of rejection in face allotransplantation. Transplantation 95, 1197\u20131203 (2013).","journal-title":"Transplantation"},{"key":"45759_CR6","doi-asserted-by":"publisher","first-page":"249ra110","DOI":"10.1126\/scitranslmed.3008778","volume":"6","author":"T Gajanayake","year":"2014","unstructured":"Gajanayake, T. et al. A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft. Science Translational Medicine 6, 249ra110 (2014).","journal-title":"Science Translational Medicine"},{"issue":"10","key":"45759_CR7","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1097\/TP.0000000000002283","volume":"102","author":"Dzhuliya V. Dzhonova","year":"2018","unstructured":"Dzhonova, D. V. et al. Local injections of tacrolimus-loaded hydrogel reduce systemic immunosuppression-related toxicity in vascularized composite allotransplantation. Transplantation 1, https:\/\/doi.org\/10.1097\/TP.0000000000002283 (2018).","journal-title":"Transplantation"},{"key":"45759_CR8","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jss.2017.05.046","volume":"218","author":"R Olariu","year":"2017","unstructured":"Olariu, R. et al. Intra-graft injection of tacrolimus promotes survival of vascularized composite allotransplantation. Journal of Surgical Research 218, 49\u201357 (2017).","journal-title":"Journal of Surgical Research"},{"key":"45759_CR9","doi-asserted-by":"publisher","first-page":"403e","DOI":"10.1097\/PRS.0000000000002951","volume":"139","author":"JV Unadkat","year":"2017","unstructured":"Unadkat, J. V. et al. Single Implantable FK506 Disk Prevents Rejection in Vascularized Composite Allotransplantation. Plastic and reconstructive surgery 139, 403e\u2013414e (2017).","journal-title":"Plastic and reconstructive surgery"},{"key":"45759_CR10","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1016\/j.jconrel.2015.08.014","volume":"219","author":"CM Dumont","year":"2015","unstructured":"Dumont, C. M., Park, J. & Shea, L. D. Controlled release strategies for modulating immune responses to promote tissue regeneration. J Control Release 219, 155\u2013166 (2015).","journal-title":"J Control Release"},{"key":"45759_CR11","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3389\/fimmu.2015.00438","volume":"6","author":"N Safinia","year":"2015","unstructured":"Safinia, N., Scotta, C., Vaikunthanathan, T., Lechler, R. I. & Lombardi, G. Regulatory T Cells: Serious Contenders in the Promise for Immunological Tolerance in Transplantation. Frontiers in Immunology 6, 438 (2015).","journal-title":"Frontiers in Immunology"},{"key":"45759_CR12","doi-asserted-by":"publisher","first-page":"87","DOI":"10.3389\/fimmu.2016.00087","volume":"7","author":"JR Scalea","year":"2016","unstructured":"Scalea, J. R., Tomita, Y., Lindholm, C. R. & Burlingham, W. Transplantation Tolerance Induction: Cell Therapies and Their Mechanisms. Frontiers in Immunology 7, 87 (2016).","journal-title":"Frontiers in Immunology"},{"key":"45759_CR13","doi-asserted-by":"publisher","first-page":"7S","DOI":"10.1016\/S0041-1345(03)00211-2","volume":"35","author":"SN Sehgal","year":"2003","unstructured":"Sehgal, S. N. Sirolimus: its discovery, biological properties, and mechanism of action. Transplantation Proceedings 35, 7S\u201314S (2003).","journal-title":"Transplantation Proceedings"},{"key":"45759_CR14","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1084\/jem.20071477","volume":"205","author":"S Haxhinasto","year":"2008","unstructured":"Haxhinasto, S., Mathis, D. & Benoist, C. The AKT-mTOR axis regulates de novo differentiation of CD4+ Foxp3+ cells. The Journal of Experimental Medicine 205, 565\u2013574 (2008).","journal-title":"The Journal of Experimental Medicine"},{"key":"45759_CR15","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1016\/j.immuni.2009.04.014","volume":"30","author":"GM Delgoffe","year":"2009","unstructured":"Delgoffe, G. M. et al. The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. Immunity 30, 832\u2013844 (2009).","journal-title":"Immunity"},{"key":"45759_CR16","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/j.intimp.2007.08.027","volume":"7","author":"H Kopf","year":"2007","unstructured":"Kopf, H., la Rosa de, G. M., Howard, O. M. Z. & Chen, X. Rapamycin inhibits differentiation of Th17 cells and promotes generation of FoxP3+\u2009T regulatory cells. Int. Immunopharmacol. 7, 1819\u20131824 (2007).","journal-title":"Int. Immunopharmacol."},{"key":"45759_CR17","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.transproceed.2012.06.067","volume":"45","author":"T Zhao","year":"2013","unstructured":"Zhao, T. et al. Comparison of regulatory T cells and FoxP3-positive T-cell subsets in the peripheral blood of renal transplant recipients with sirolimus versus cyclosporine: a preliminary study. Transplantation Proceedings 45, 148\u2013152 (2013).","journal-title":"Transplantation Proceedings"},{"key":"45759_CR18","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1111\/j.1432-2277.2009.00890.x","volume":"22","author":"TK Hendrikx","year":"2009","unstructured":"Hendrikx, T. K. et al. Monotherapy rapamycin allows an increase of CD4 CD25 FoxP3 T cells in renal recipients. Transplant International 22, 884\u2013891 (2009).","journal-title":"Transplant International"},{"key":"45759_CR19","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.transproceed.2012.07.145","volume":"45","author":"Z-Q Chu","year":"2013","unstructured":"Chu, Z.-Q. & Ji, Q. Sirolimus did not affect CD4(+)CD25(high) forkhead box p3(+)T cells of peripheral blood in renal transplant recipients. Transplantation Proceedings 45, 153\u2013156 (2013).","journal-title":"Transplantation Proceedings"},{"key":"45759_CR20","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/ki.2014.350","volume":"87","author":"L Gallon","year":"2015","unstructured":"Gallon, L. et al. Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus. Kidney International 87, 828\u2013838 (2015).","journal-title":"Kidney International"},{"key":"45759_CR21","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/imm.12351","volume":"144","author":"KW Kim","year":"2015","unstructured":"Kim, K. W., Chung, B. H., Kim, B.-M., Cho, M.-L. & Yang, C. W. The effect of mammalian target of rapamycin inhibition on T helper type 17 and regulatory T cell differentiation in vitro and in vivo in kidney transplant recipients. Immunology 144, 68\u201378 (2015).","journal-title":"Immunology"},{"key":"45759_CR22","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0168-3659(98)00158-8","volume":"58","author":"PD Graham","year":"1999","unstructured":"Graham, P. D., Brodbeck, K. J. & McHugh, A. J. Phase inversion dynamics of PLGA solutions related to drug delivery. J Control Release 58, 233\u2013245 (1999).","journal-title":"J Control Release"},{"key":"45759_CR23","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1016\/S0168-3659(99)00159-5","volume":"62","author":"KJ Brodbeck","year":"1999","unstructured":"Brodbeck, K. J., DesNoyer, J. R. & McHugh, A. J. Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. J Control Release 62, 333\u2013344 (1999).","journal-title":"J Control Release"},{"key":"45759_CR24","doi-asserted-by":"crossref","unstructured":"Cendales, L. C. et al. The Banff 2007 working classification of skin-containing composite tissue allograft pathology. In 8, 1396\u20131400 (Blackwell Publishing Ltd, 2008).","DOI":"10.1111\/j.1600-6143.2008.02243.x"},{"key":"45759_CR25","first-page":"721","volume":"28","author":"LS Nguyen","year":"2019","unstructured":"Nguyen, L. S. et al. Sirolimus and mTOR Inhibitors: A Review of Side Effects and Specific Management in Solid Organ Transplantation. Drug Saf 28, 721\u201313 (2019).","journal-title":"Drug Saf"},{"key":"45759_CR26","doi-asserted-by":"publisher","first-page":"e0203409","DOI":"10.1371\/journal.pone.0203409","volume":"13","author":"D Dzhonova","year":"2018","unstructured":"Dzhonova, D. et al. Local release of tacrolimus from hydrogel-based drug delivery system is controlled by inflammatory enzymes in vivo and can be monitored non-invasively using in vivo imaging. PLoS ONE 13, e0203409 (2018).","journal-title":"PLoS ONE"},{"key":"45759_CR27","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.smim.2017.03.001","volume":"29","author":"A Nair","year":"2017","unstructured":"Nair, A. & Tang, L. Influence of scaffold design on host immune and stem cell responses. Seminars in Immunology 29, 62\u201371 (2017).","journal-title":"Seminars in Immunology"},{"key":"45759_CR28","doi-asserted-by":"publisher","first-page":"831410","DOI":"10.1155\/2013\/831410","volume":"2013","author":"M Siemionow","year":"2013","unstructured":"Siemionow, M. & Klimczak, A. Chimerism-based experimental models for tolerance induction in vascularized composite allografts: Cleveland clinic research experience. Clin. Dev. Immunol. 2013, 831410\u201312 (2013).","journal-title":"Clin. Dev. Immunol."},{"key":"45759_CR29","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm0516-448","volume":"22","author":"AB Keener","year":"2016","unstructured":"Keener, A. B. Saving face: The search for alternatives to life-long immunosuppression for face transplants. Nature Medicine 22, 448\u2013449 (2016).","journal-title":"Nature Medicine"},{"key":"45759_CR30","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1111\/ajt.13694","volume":"16","author":"CH Lin","year":"2016","unstructured":"Lin, C. H. et al. Combined Anti-CD154\/CTLA4Ig Costimulation Blockade-Based Therapy Induces Donor-Specific Tolerance to Vascularized Osteomyocutaneous Allografts. American Journal of Transplantation 16, 2030\u20132041 (2016).","journal-title":"American Journal of Transplantation"},{"issue":"6","key":"45759_CR31","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1111\/ajt.13154","volume":"15","author":"N. Pilat","year":"2015","unstructured":"Pilat, N. et al. Rapamycin and CTLA4Ig Synergize to Induce Stable Mixed Chimerism Without the Need for CD40 Blockade. American Journal of Transplantation n\/a\u2013n\/a, https:\/\/doi.org\/10.1111\/ajt.13154 (2015).","journal-title":"American Journal of Transplantation"},{"key":"45759_CR32","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/ajt.12275","volume":"13","author":"CH Lin","year":"2013","unstructured":"Lin, C. H. et al. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy. American Journal of Transplantation 13, 2161\u20132168 (2013).","journal-title":"American Journal of Transplantation"},{"key":"45759_CR33","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/ajt.12964","volume":"15","author":"N Poirier","year":"2015","unstructured":"Poirier, N. et al. FR104, an antagonist anti-CD28 monovalent fab\u2019 antibody, prevents alloimmunization and allows calcineurin inhibitor minimization in nonhuman primate renal allograft. American Journal of Transplantation 15, 88\u2013100 (2015).","journal-title":"American Journal of Transplantation"},{"key":"45759_CR34","doi-asserted-by":"publisher","first-page":"3433","DOI":"10.4049\/jimmunol.0904028","volume":"184","author":"AM Thornton","year":"2010","unstructured":"Thornton, A. M. et al. Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+\u2009T regulatory cells. J. Immunol. 184, 3433\u20133441 (2010).","journal-title":"J. Immunol."},{"key":"45759_CR35","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.4049\/jimmunol.1201379","volume":"190","author":"ME Himmel","year":"2013","unstructured":"Himmel, M. E., MacDonald, K. G., Garcia, R. V., Steiner, T. S. & Levings, M. K. Helios+\u2009and Helios- cells coexist within the natural FOXP3+\u2009T regulatory cell subset in humans. J. Immunol. 190, 2001\u20132008 (2013).","journal-title":"J. Immunol."},{"key":"45759_CR36","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3389\/fimmu.2016.00276","volume":"7","author":"E Elkord","year":"2016","unstructured":"Elkord, E. Helios Should Not Be Cited as a Marker of Human Thymus-Derived Tregs. Commentary: Helios(+) and Helios(-) Cells Coexist within the Natural FOXP3(+) T Regulatory Cell Subset in Humans. Frontiers in Immunology 7, 276 (2016).","journal-title":"Frontiers in Immunology"},{"key":"45759_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.4049\/jimmunol.1501704","volume":"196","author":"M Sebastian","year":"2016","unstructured":"Sebastian, M. et al. Helios Controls a Limited Subset of Regulatory T Cell Functions. J. Immunol. 196, 144\u2013155 (2016).","journal-title":"J. Immunol."},{"key":"45759_CR38","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1126\/science.aad0616","volume":"350","author":"H-J Kim","year":"2015","unstructured":"Kim, H.-J. et al. Stable inhibitory activity of regulatory T cells requires the transcription factor Helios. Science 350, 334\u2013339 (2015).","journal-title":"Science"},{"key":"45759_CR39","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1097\/TP.0b013e318200e97","volume":"91","author":"J Levitsky","year":"2011","unstructured":"Levitsky, J. et al. Allospecific regulatory effects of sirolimus and tacrolimus in the human mixed lymphocyte reaction. Transplantation 91, 199\u2013206 (2011).","journal-title":"Transplantation"},{"key":"45759_CR40","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1111\/ajt.13910","volume":"17","author":"JS Young","year":"2017","unstructured":"Young, J. S. et al. Erosion of Transplantation Tolerance After Infection. American Journal of Transplantation 17, 81\u201390 (2017).","journal-title":"American Journal of Transplantation"},{"key":"45759_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms8566","volume":"6","author":"ML Miller","year":"2015","unstructured":"Miller, M. L. et al. Spontaneous restoration of transplantation tolerance after acute rejection. Nature Communications 6, 7566 (2015).","journal-title":"Nature Communications"},{"key":"45759_CR42","doi-asserted-by":"publisher","first-page":"351ra105","DOI":"10.1126\/scitranslmed.aae0501","volume":"8","author":"A Chhabra","year":"2016","unstructured":"Chhabra, A. et al. Hematopoietic stem cell transplantation in immunocompetent hosts without radiation or chemotherapy. Science Translational Medicine 8, 351ra105\u2013351ra105 (2016).","journal-title":"Science Translational Medicine"},{"key":"45759_CR43","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jss.2012.02.064","volume":"178","author":"J-Y Lin","year":"2012","unstructured":"Lin, J.-Y. et al. Optimizing chimerism level through bone marrow transplantation and irradiation to induce long-term tolerance to composite tissue allotransplantation. J. Surg. Res. 178, 487\u2013493 (2012).","journal-title":"J. Surg. Res."},{"key":"45759_CR44","doi-asserted-by":"publisher","first-page":"E156","DOI":"10.1073\/pnas.1408686111","volume":"112","author":"RA Maldonado","year":"2015","unstructured":"Maldonado, R. A. et al. Polymeric synthetic nanoparticles for the induction of antigen-specific immunological tolerance. Proceedings of the National Academy of Sciences 112, E156\u2013E165 (2015).","journal-title":"Proceedings of the National Academy of Sciences"},{"key":"45759_CR45","doi-asserted-by":"publisher","first-page":"2940","DOI":"10.1016\/j.celrep.2016.08.033","volume":"16","author":"LH Tostanoski","year":"2016","unstructured":"Tostanoski, L. H. et al. Reprogramming the Local Lymph Node Microenvironment Promotes Tolerance that Is Systemic and Antigen Specific. Cell Reports 16, 2940\u20132952 (2016).","journal-title":"Cell Reports"},{"key":"45759_CR46","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1111\/bcp.12893","volume":"82","author":"M Waldner","year":"2016","unstructured":"Waldner, M., Fantus, D., Solari, M. & Thomson, A. W. New perspectives on mTOR inhibitors (rapamycin, rapalogs and TORKinibs) in transplantation. Br J Clin Pharmacol 82, 1158\u20131170 (2016).","journal-title":"Br J Clin Pharmacol"},{"key":"45759_CR47","doi-asserted-by":"publisher","unstructured":"Taddeo, A., Tsai, C., V\u00f6gelin, E. & Rieben, R. Novel targeted drug delivery systems to minimize systemic immunosuppression in vascularized composite allotransplantation. Current opinion in organ transplantation 1, https:\/\/doi.org\/10.1097\/MOT.0000000000000564 (2018).","DOI":"10.1097\/MOT.0000000000000564"},{"key":"45759_CR48","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1097\/TP.0b013e3181bbee98","volume":"88","author":"J Levitsky","year":"2009","unstructured":"Levitsky, J. et al. The human \u2018Treg MLR\u2019: immune monitoring for FOXP3+\u2009T regulatory cell generation. Transplantation 88, 1303\u20131311 (2009).","journal-title":"Transplantation"},{"issue":"5","key":"45759_CR49","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1111\/ajt.13118","volume":"15","author":"R. Jindal","year":"2015","unstructured":"Jindal, R. et al. Spontaneous Resolution of Acute Rejection and Tolerance Induction With IL-2 Fusion Protein in Vascularized Composite Allotransplantation. American Journal of Transplantation n\/a\u2013n\/a, https:\/\/doi.org\/10.1111\/ajt.13118 (2015).","journal-title":"American Journal of Transplantation"},{"key":"45759_CR50","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1097\/SLA.0b013e3181f3efb0","volume":"252","author":"G Orlando","year":"2010","unstructured":"Orlando, G. et al. Clinical operational tolerance after renal transplantation: current status and future challenges. Ann. Surg. 252, 915\u2013928 (2010).","journal-title":"Ann. Surg."},{"key":"45759_CR51","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.ijpharm.2006.09.033","volume":"332","author":"H Kranz","year":"2007","unstructured":"Kranz, H. & Bodmeier, R. A novel in situ forming drug delivery system for controlled parenteral drug delivery. Int J Pharm 332, 107\u2013114 (2007).","journal-title":"Int J Pharm"},{"key":"45759_CR52","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.jconrel.2012.04.016","volume":"161","author":"S Kempe","year":"2012","unstructured":"Kempe, S. & M\u00e4der, K. In situ forming implants - an attractive formulation principle for parenteral depot formulations. J Control Release 161, 668\u2013679 (2012).","journal-title":"J Control Release"},{"key":"45759_CR53","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1053\/jhsu.2002.32078","volume":"27","author":"E V\u00f6gelin","year":"2002","unstructured":"V\u00f6gelin, E., Jones, N. F. & Rao, U. N. M. Long-term viability of articular cartilage after microsurgical whole-joint transplantation and immunosuppression with rapamycin, mycophenolate mofetil, and tacrolimus. The Journal of Hand Surgery 27, 307\u2013315 (2002).","journal-title":"The Journal of Hand Surgery"},{"key":"45759_CR54","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1159\/000327972","volume":"47","author":"J Weinreich","year":"2011","unstructured":"Weinreich, J. et al. Rapamycin-induced impaired wound healing is associated with compromised tissue lactate accumulation and extracellular matrix remodeling. Eur Surg Res 47, 39\u201344 (2011).","journal-title":"Eur Surg Res"},{"key":"45759_CR55","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1016\/S0022-1759(03)00236-9","volume":"279","author":"J-C Chen","year":"2003","unstructured":"Chen, J.-C., Chang, M.-L. & Muench, M. O. A kinetic study of the murine mixed lymphocyte reaction by 5,6-carboxyfluorescein diacetate succinimidyl ester labeling. Journal of Immunological Methods 279, 123\u2013133 (2003).","journal-title":"Journal of Immunological Methods"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45759-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45759-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,17]],"date-time":"2022-12-17T05:55:14Z","timestamp":1671256514000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-019-45759-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,25]]},"references-count":55,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["45759"],"URL":"https:\/\/doi.org\/10.1038\/s41598-019-45759-y","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,25]]},"assertion":[{"value":"13 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 June 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9269"}}